Risks and burden of viral respiratory tract infections in patients with multiple myeloma in the era of immunomodulatory drugs and bortezomib: experience at an Australian Cancer Hospital

INTRODUCTION: Infections are a leading cause of morbidity and mortality in patients with multiple myeloma. The epidemiology, risk factors and outcomes of viral respiratory tract infections (vRTI) are not well described in patients with multiple myeloma managed with novel agents, the current standard...

Descripción completa

Detalles Bibliográficos
Autores principales: Teh, Benjamin W., Worth, Leon J., Harrison, Simon J., Thursky, Karin A., Slavin, Monica A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7087950/
https://www.ncbi.nlm.nih.gov/pubmed/25487843
http://dx.doi.org/10.1007/s00520-014-2550-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7087950/
https://www.ncbi.nlm.nih.gov/pubmed/25487843
http://dx.doi.org/10.1007/s00520-014-2550-3

Ejemplares similares